Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Our clients are sourcing and developing unique omega-3 fatty acids from green lipped mussels for the treatment of joints, asthma and dermatitis in animals. More
Rheumatoid arthritis More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Hypoallergenic moisturizing cream for dermatitis and dehydrated skin espcially formulated for sensitive skin, thanks to the total absence of preservayives and perfumes More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
more effective methods for preparing 2-sufonyloxy-1-phenylethanol derivatives in a high yield and a high e.e. value are now required in the industries of pharmacy More
Related Reports
Market Research Reports provided by reports.iptechex.com
Oct 2011 - 89 pages - $3,500
Oct 2011 - 68 pages - $3,500
Feb 2011 - 58 pages - $500
Sep 2010 - 38 pages - $2,000
Sep 2011 - 117 pages - $500
Nov 2010 - 50 pages - $500
Jun 2011 - 77 pages - $1,000
Nov 2009 - 142 pages - $2,350
Mar 2011 - 75 pages - $500
Jun 2006 - 434 pages - $2,495
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us